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ABSTRACT

ARTICLE HISTORY

Cell differentiation is associated with changes in chromatin organization and gene expression. In
this study, we examine chromatin structure following differentiation of the human myeloid
leukemia cell line (HL-60/S4) into granulocytes with retinoic acid (RA) or into macrophage with
phorbol ester (TPA). We performed ChIP-seq of histone H3 and its modiﬁcations, analyzing changes
in nucleosome occupancy, nucleosome repeat length, eu-/heterochromatin redistribution and
properties of epichromatin (surface chromatin adjacent to the nuclear envelope). Nucleosome
positions changed genome-wide, exhibiting a speciﬁc class of alterations involving nucleosome loss
in extended (»1kb) regions, pronounced in enhancers and promoters. Genes that lost nucleosomes
at their promoters showed a tendency to be upregulated. On the other hand, nucleosome gain did
not show simple effects on transcript levels. The average genome-wide nucleosome repeat length
(NRL) did not change signiﬁcantly with differentiation. However, we detected an approximate 10 bp
NRL decrease around the haematopoietic transcription factor (TF) PU.1 and the architectural protein
CTCF, suggesting an effect on NRL proximal to TF binding sites. Nucleosome occupancy changed in
regions associated with active promoters in differentiated cells, compared with untreated HL-60/S4
cells. Epichromatin regions revealed an increased GC content and high nucleosome density
compared with surrounding chromatin. Epichromatin showed depletion of major histone
modiﬁcations and revealed enrichment with PML body-associated genes. In general, chromatin
changes during HL-60/S4 differentiation appeared to be more localized to regulatory regions,
compared with genome-wide changes among diverse cell types studied elsewhere.
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Introduction
Cell differentiation is known to be accompanied by
chromatin changes and, in particular, nucleosome
repositioning,1-6 since only about 37.5% of human
nucleosomes have DNA sequence-determined positions.7 The magnitude of chromatin changes and their
effect on gene expression depend upon the particular
biologic system. Here, we consider 2 differentiation
pathways of the human cell line HL-60/S4.
The immortalized myeloid leukemia cell line (HL-60),
isolated from a female patient, was originally described to
be an acute promyelocytic leukemia (APL);8,9 but was
subsequently reclassiﬁed as an acute myeloblastic
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leukemia (AML) with maturation.10 HL-60 cells are multipotential and can be readily differentiated into granulocytes with DMSO9 or retinoic acid (RA),10 into
monocytes with vitamin D3,11,12 or into macrophage
with phorbol ester (TPA).12,13 The multipotential character of HL-60 cells to differentiate along various myeloid
directions was summarized in an early review by one of
the original discoverers of this important cell line.14 The
mutagenically-derived subline HL-60/S4 available
through ATCC as #CRL-3306, exhibits distinctly faster
differentiation than the parent HL-60 cell line.15 HL-60/
S4 cells develop granulocytic nuclear segmentation in
4 d, whereas the parent HL-60 line requires at least 6 d
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for the same level of differentiation.16 We have previously
studied HL-60/S4, exploring nuclear shape, chromatin
structure and cytoskeletal changes during differentiation
induced by RA, TPA and vitamin D3.17-23 Furthermore,
we have recently introduced the concept of “epichromatin,” which involves a small percentage (»5%) of the HL60/S4 genome, is highly enriched with retrotransposon
Alu, and is reproducibly located adjacent to the nuclear
envelope in undifferentiated, RA and TPA treated HL60/S4 cells.23 While being adjacent to the nuclear envelope, this type of regions should be distinguished from
lamina-associated domains (LADs) deﬁned elsewhere,2426
because epichromatin regions are identiﬁed after short
formaldehyde ﬁxation times (“snapshots”); whereas
LADs are deﬁned after longer transfection times, yielding
30–40% of the genome. Most recently, we have also
described the transcriptomes of the undifferentiated,
granulocytic and macrophage forms of HL-60/S4.27
Differential gene expression, the basic mechanism
underlying cell differentiation, depends upon a complex interplay between nucleosome positioning, histone and DNA covalent modiﬁcations and chromatin
binding proteins.3,28 Integrating these various changes
at individual promoters represents a current frontier
in understanding the molecular biology of cell differentiation and cancer formation. In recent studies, epigenetic proﬁling has been performed in several blood
cells types to study the differentiation-induced
changes of the epigenome. For example, the BLUEPRINT consortium studied the differentiation of puriﬁed circulating monocytes from healthy volunteers
into macrophages, and quantiﬁed this process in terms
of the correlation of changes of H3K4me1, H3K4me3,
H3K27ac, and DNase I accessibility with changes of
gene expression.29 A more recent study has followed
up this analysis, including 3 additional histone modiﬁcations and DNA methylation data, as well as performing NOME-seq to study the relation of
nucleosome positioning with DNA methylation.5
However, the change of the chromatin density per se
was not systematically analyzed in these works. Perhaps, one of the reasons for this is the intrinsic variability of nucleosome positions between healthy
individuals – this problem can be overcome by using
well-deﬁned cell lines rather than primary cells. For
example, in single-cell studies it is possible to distinguish quite nicely between HL-60 and GM12878 cells
just by the characteristic differences of the chromatin
accessibilities30
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In the present study, we have performed ChIP-seq
with antibodies against histone H3 and 6 histone H3
modiﬁcations, combining these data with the RNAseq to characterize the differentiation-speciﬁc chromatin changes in the HL-60/S4 cell system.

Results
Nucleosome repositioning at promoters and
enhancers

We have determined nucleosome occupancy proﬁles
using Micrococcal Nuclease (MNase)-assisted ChIPseq with H3 antibody in untreated, RA-treated and
TPA-treated HL-60/S4 cells. Complex scenarios of
nucleosome gain or loss and nucleosome repositioning
take place upon HL-60/S4 cells differentiation into
granulocyte (RA-treated) or macrophage (TPAtreated) cell forms. Using a “sliding window”
approach with the help of NucTools software,31 we
deﬁned 1000-bp genomic regions which are characterized by signiﬁcant loss or gain of nucleosome occupancy upon differentiation with RA or TPA (see
Methods). We have identiﬁed 22,024 regions with
nucleosome loss and 224,140 regions with nucleosome
gain upon RA treatment. Similarly, there were 28,732
regions with nucleosome loss and 237,850 regions
with nucleosome gain upon TPA treatment. This is
different from the previous NOME-seq study in primary monocyte cells differentiating into macrophages,
which claimed preferential nucleosome depletions
upon differentiation.5 These data are not directly comparable since we were calling ﬁxed-size 1000-bp windows of differential histone H3 occupancy, while the
NOME-seq study was calling single-nucleosome
peaks, but the difference is interesting anyway.
Figure 1A and B present the statistics of differential
gain/loss of nucleosomes in 3 types of HL-60/S4 genomic
regions (promoters, enhancers and retrotransposon Alu
elements) as a consequence of RA or TPA treatment.
Promoters and enhancers were enriched within regions
that lost nucleosomes, but not enriched within regions
that gained nucleosomes. Alu elements showed no significant gain or loss of nucleosomes. Promoters of upregulated genes that lost nucleosomes upon RA treatment
were enriched within a very large number of KEGG pathways including among others “B-cell receptor signaling
pathway” (P D 9.5e-5) and “T cell receptor signaling” (P
D 1.4e-3). Promoters of downregulated genes that lost
nucleosomes upon RA treatment were enriched only

190

V. B. TEIF ET AL.

Figure 1. Statistics of the distribution of regions that gained or lost nucleosomes upon HL-60/S4 differentiation by RA (A) or TPA (B),
among different functional elements (enhancers, promoters, Alu repeats). Bar color code: light blue, nucleosomes gained, relative to 0
(undifferentiated) cells; yellow, nucleosomes lost, relative to 0. Fold enrichment equal to 1.0 signiﬁes that a given genomic feature
exhibits no net change in nucleosome numbers. Following RA or TPA treatment, more nucleosomes are lost, than are gained, in promoters and enhancers; but this is not observed with Alu repeat sequences. (C-D) Relation between changes of gene expression and
nucleosome repositioning upon RA treatment (C) and TPA treatment (D). “Number of genes up/down,” the number of up or downregulated genes for 3 groups: “All genes,” all signiﬁcantly expressed genes; “Nuc lost,” genes that lost nucleosomes at their promoters; “Nuc
gained,” genes that gained nucleosomes at their promoters. The group of genes that lost nucleosomes at their promoters contains a
larger proportion of upregulated genes, than the group of genes that gained nucleosomes at the promoter.

with “DNA replication” (P D 2.7e-3) and “mismatch
repair” pathways (P D 6.6e-3). Promoters of upregulated
genes that lost nucleosomes upon TPA treatment were
most signiﬁcantly enriched for “cGMP-PKG
signaling” (P D 4.4e-5) and “cAMP signaling” pathways
(P D 2.8e-3). Promoters of downregulated genes that lost
nucleosomes upon TPA treatment were enriched with
“propanoate metabolism” (P D 1.3e-4) and “butanoate
metabolism” pathways (P D 6.8e-4).
A typical parameter of chromatin structural
changes occurring during cell differentiation is “nucleosome occupancy,” which can be interpreted as the

fraction of cells from the population in which a given
region of DNA is occupied by a histone octamer.32
Figure 1C and D show that when comparing the numbers of up/downregulated genes with lost nucleosomes, the genes which have lost nucleosomes were
preferentially upregulated (i.e., increased transcript
levels) compared with those which gained nucleosomes or to all genes. In particular, the ratio of the
number of upregulated versus downregulated genes
was around 1.14, both for “all genes” and for genes
that gained nucleosomes at their promoters. On the
other hand, this ratio (up/down gene regulation)

NUCLEUS
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Figure 2. Examples of nucleosome repositioning in genes that exhibit signiﬁcant changes in mRNA levels in the differentiated state,
compared with the undifferentiated HL-60/S4 cell form. A blue-green bar under the X-axis shows the gene body and the direction of
transcription is indicated by an arrow. Promoters are deﬁned as (C/¡1000 bp) centered around the TSS (Transcription Start Site). Plot
line colors: O (undifferentiated), black; RA treated, red; TPA treated, blue. Images available in color online.

increased to 1.39 and 1.5 for genes that lost nucleosomes at their promoters upon treatment by RA and
TPA, respectively. Fisher’s exact test conﬁrmed that
nucleosome loss at promoters upon RA treatment correlates with a signiﬁcant increase in the number of
upregulated genes (x2-test, P D 1.7e-5); but the difference for genes that gained nucleosomes was not significant (x2-test, P D 0.64). The same effect was observed
for TPA-treated genes.
Figure 2 presents nucleosome occupancy changes for
speciﬁc genes belonging to haematopoietic differentiation pathways that have lost nucleosomes in promoter
regions, comparing undifferentiated (O) to differentiated (RA and TPA) cell forms. This set of genes generally exhibited large increases in transcript levels after
both RA and TPA treatment (with the exception of
CD38, which showed a decrease after TPA). At our H3

ChIP-seq resolution, we mostly observe distinct changes
that can be localized to regions enclosing 1–5 nucleosomes. The loss of nucleosomes and corresponding
increase of gene expression is particularly apparent in
the CD38 (RA), IRF7 (RA and TPA), EGR2 (RA) and
EGR3 (RA and TPA) gene examples. On the other
hand, nucleosome gain does not seem to correlate with
changes of gene expression, as exempliﬁed in Supplementary Figure S1. Thus, nucleosome loss in promoter
regions, but not nucleosome gain, appears to be a particular functional mechanism during HL-60/S4 differentiation by RA and TPA.
Nucleosome repeat length during cell differentiation

Global nucleosome repeat length (NRL) was calculated for undifferentiated, RA and TPA-treated HL-
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Figure 3. Nucleosome repeat length (NRL) in different cell states and genomic regions. (A) Genome-wide average NRL is 192 bp without
signiﬁcant difference upon HL-60/S4 differentiation by RA or TPA. (B) Average nucleosome occupancy proﬁle around bound CTCF. The
corresponding NRL values are indicated on the ﬁgure. (C) Average nucleosome occupancy around bound PU.1 transcription factor. (D)
The same as (C), but only the density of “C” strand reads is shown. The NRL determined for nucleosomes periodically arranged near
PU.1 sites is indicated on this panel. The locations of CTCF and PU.1 binding sites were obtained from ENCODE ChIP-seq data on undifferentiated HL-60 cells; nucleosome positions were calculated from present data on undifferentiated and differentiated HL-60/S4 cells.
Plot line colors: O (undifferentiated), black; RA treated, red; TPA treated, blue.

60/S4 cells, following the calculation procedure
described previously.2,3,33 Fig. 3A demonstrates that
there are no signiﬁcant differences in global NRL (192
C/¡1.5 bp) among the 3 cell states. This apparent
constancy of NRL within the HL-60/S4 cell states is
interesting, because, for example, the genome-wide
NRL values measured for mouse embryonic stem cells
differentiation varied by 5–7 bp.3
As pointed out in the earlier publications,3,33 speciﬁc genomic regions may display local variations and
marked differences from the global NRL values. One
such example is shown in Fig. 3B, which illustrates the

global nucleosome occupancy surrounding CTCF
binding sites in HL-60/S4 cells (undifferentiated,
180.8 C/¡2.0 bp; RA, 181.8 C/¡2.6 bp; TPA, 181.2
C/¡2.4 bp), which is »10 bp smaller than the global
average NRL. The center of the CTCF binding site
exhibits a clear deﬁciency of bound nucleosomes,
compared with the adjacent chromatin environment.
Another speciﬁc example is the nucleosome occupancy around bound PU.1 transcription factors in the
3 HL-60/S4 cell states (Fig. 3C and D). The NRL values change by »2 bp during cell differentiation
(undifferentiated, 177.4 C/¡2.5 bp; RA, 179.4 C/¡3.2
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bp; TPA, 179.7 C/¡2.0 bp). The chromatin region
around bound PU.1 has »12 bp shorter NRL than the
global NRL, and is also slightly smaller than that for
CTCF. It remains to be demonstrated how general is
the change in NRL around transcription factor (TF)
binding sites, and whether such changes depend upon
TF binding. In the examples above, we used CTCF
and PU.1 binding sites determined by ChIP-seq in
HL-60 cells by the ENCODE consortium.34
Nucleosome occupancy changes associated with
histone modiﬁcations

We have determined histone modiﬁcations using
ChIP-seq in untreated, RA-treated and TPA-treated
HL-60/S4 cells. As shown previously for other differentiation systems, nucleosome occupancy signatures
of different histone modiﬁcation domains vary signiﬁcantly.3 The differentiation of HL-60/S4 is no exception. Figure 4 illustrates the nucleosome occupancy
proﬁles of chromatin domains of 4 different histone
modiﬁcations that are related to chromatin functions,
comparing nucleosome occupancy in undifferentiated,
RA- and TPA-differentiated cell states. Sites that were
enriched with H3K4me3 (a marker for active promoters) in untreated cells reveal reduced (but still
apparent) nucleosome occupancy in the center of their
domain following treatment with RA or TPA
(Fig. 4A). Sites that were enriched with H3K4me1,
H3K9ac and H3K27ac in untreated cells reveal less
dramatic changes in nucleosome occupancy following
treatment (Fig. 4B, C and D). In contrast to activating
marks, the sites enriched with H3K4me1 (which can
be associated with repression)35 in untreated cells
appear to show an increased nucleosome occupancy
following either treatment. The ﬁnding that major
decrease of the nucleosome density peak occurs at
H3K4me3 sites in undifferentiated HL-60 cells is consistent with our statistics shown in Fig. 1A and B,
which suggests signiﬁcant nucleosome loss at some
promoters upon HL-60/S4 differentiation.
Nucleosome features in HL-60/S4 epichromatin

Using the new data on nucleosome positioning and
histone modiﬁcations during HL-60/S4 differentiation
obtained in this study, we attempt to deepen our
understanding of “epichromatin” regions, previously
mapped in undifferentiated, RA and TPA treated HL60/S4 cells.23 The concept of epichromatin (i.e., the
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surface of chromatin adjacent to the interphase
nuclear envelope and at the “outer” surface of mitotic
chromosomes) is based upon speciﬁcally localized
immunostaining experiments.36,37 Two mouse monoclonal antibodies of divergent origin, PL2–638 and
1H6,39 yield identical staining patterns on ﬁxed and
permeabilized cells of considerable phylogenetic diversity, spanning from human to plant cells,36,37 implying
the existence of a conserved chromatin epitope.
Recently, 2 of us (ALO and DEO) enriched and characterized epichromatin from ﬁxed and sonicated HL60/S4 cells (0, RA and TPA cell states) by using a
modiﬁed immunoprecipitation method (“xxChIPseq”) using PL2–6 and 1H6.23 Some of the previously
described characteristics of HL-60/S4 epichromatin
regions include: 1) Representation of only »5% of the
human genome. 2) Enrichment of retrotransposon
Alu, »10-fold more concentrated than average for the
human genome. 3) Epichromatin regions averaged
»1 kb in size. 4) Epichromatin-containing DNA
sequences, derived from 0, RA and TPA cells reacted
with PL2–6 and 1H6 revealed a discontinuous distribution along each chromosome, which appeared to be
relatively constant in chromosome location, comparing the 3 cell states. Still, the question of what exactly
is epichromatin remains unanswered, and therefore
we investigated the relationship between epichromatin
regions and nucleosome occupancy changes during
HL-60/S4 differentiation.
Since ChIP-seq is inherently a very noisy technique,
we computed a list of common epichromatic regions,
deﬁned as the intersection of all replicate experiments
between untreated and RA-treated cells. The intersection of 2 genomic regions is deﬁned in the following
way: 2 regions intersect if they share at least one base
pair (based on their genomic coordinates). As input for
these calculations, we took the coordinates of epichromatic regions for each replicate experiment reported
earlier.23 Deﬁned in this way, replicate PL2–6 immunoprecipitates of undifferentiated HL-60/S4 cells exhibited
40,288 epichromatin regions; replicate RA-treated cells,
77,897 regions. Deﬁning only common regions based
on all replicates, both antibodies (PL2–6 and 1H6) and
2 cell states (undifferentiated and RA-treated) resulted
in 6541 common epichromatin regions.
We have found the following 3 properties of the
common HL-60/S4 epichromatin regions: (1) Alu
enrichment, compared with average genomic background levels, is about 2-fold at the center of
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Figure 4. Nucleosome occupancies at different histone modiﬁcation domains exhibit changes upon HL-60/S4 differentiation with
RA or TPA. Panels: (A) H3K4me3; (B) H3K4me1; (C) H3K9ac; (D) H3K27ac. The largest changes occur in H3K4me3 domains, indicating major nucleosome loss at promoters upon HL-60/S4 differentiation (consistent with Fig. 1A and B). Coordinates of
H3K4me1, H3K9ac and H3K27ac domains are obtained from the corresponding ChIP-seq experiments performed in this study.
Coordinates of H3K4me3 domains are based upon ENCODE ChIP-seq data on undifferentiated HL-60 cells; nucleosome occupancy was calculated from present data on undifferentiated and differentiated HL-60/S4 cells. Plot line colors: O (undifferentiated), black; RA treated, red; TPA treated, blue.

epichromatin, falling to background at C/¡2.5 kb from
the center of the distribution (Fig. 5A). (2) The average
nucleotide frequency reveals increased GC nucleotide
content at the center of epichromatin (Fig. 5B). (3)
Nucleosome occupancy (i.e., histone H3 read density)
in common epichromatin regions exhibits a similar
spatial distribution (comparing O, RA and TPA),
showing highest occupancy in the center, declining to
background levels at C/¡ »2 kb (Fig. 5C). This latter
analysis is consistent with the notion that the epichromatin epitope is highly exposed within the

epichromatin regions. In addition, »12% of the epichromatin data set from PL2–6 and 1H6 antibody
experiments on untreated cells intersect with broad
DNase I sensitive regions (identiﬁed in ENCODE for
HL-60 cells).34 These results imply a signiﬁcant enrichment of “open” chromatin within epichromatin
regions. On the other hand, the calculated NRL, based
on all candidate epichromatin regions, was not different from the genome-wide NRL, while the number of
conﬁrmed common epichromatin regions was too
small to quantify NRL.
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Figure 5. Average feature distribution of common HL-60/S4 epichromatin regions as a function of the distance from the center of these
regions. (A) Enrichment of retrotransposon Alu repeats. (B) Nucleotide frequencies. (C) Nucleosome occupancy proﬁles. Plot line colors
for panel C: O (undifferentiated), black; RA treated, red; TPA treated, blue.

Signatures of histone post-translational modiﬁcations within common epichromatin regions are presented in Fig. 6. In all cases, modiﬁcations show a
reduced presence in the middle of epichromatin:
H3K9me3, a marker for constitutive heterochromatin
(Fig. 6A); H3K4me3 (Fig. 6B) and H3K9ac (Fig. 6C),
both markers for active promoters (although H3K9ac
appears to be less depressed in TPA-treated cells);
H3K27ac (Fig. 6D) and H3K4me1 (Fig. 6E), both
markers for active enhancers; and H3K36me3
(Fig. 6F), a marker for actively transcribing genes. In
summary, from the perspective of histone post-translational modiﬁcations, epichromatin is not clearly transcriptionally repressed, nor transcriptionally active.

Finally, our analysis of the common epichromatin
regions revealed a signiﬁcant increase in gene promoters, compared with the average promoter density
in the total human genome. Six percent of epichromatin regions contain promoters, corresponding to a 2.3fold enrichment with respect to the genome average.
Gene ontology (GO) analysis of these enriched promoters, unexpectedly, revealed enrichment for genes
related to PML bodies (Fig. 7A and Supplementary
Table 1). It is not clear what is the functional signiﬁcance of having so many (i.e., 41) PML-associated
genes in proximity to the interphase nuclear envelope
(by virtue of their close continuity to epichromatin).
The changes in transcript levels, compared with
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Figure 6. Signatures of histone modiﬁcation marks around common epichromatin regions. Panels: (A) H3K9me3; (B) H3K4me3; (C)
H3K9ac; (D) H3K27ac; (E) H3K4me1; (F) H3K36me3. Plot line colors: O (undifferentiated), black; RA treated, red; TPA treated,
blue.
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Figure 7. (A) Gene Ontology (GO) analysis of common epichromatin promoter regions, indicating that these domains are enriched in
genomic regions containing genes related to PML bodies. (B and C) Illustrating that PML bodies may have variable composition within
the differentiated states: (B) Nucleosome repositioning in the PML gene, comparing 0, RA and TPA cell states; (C) Nucleosome repositioning in the SP100 gene, comparing 0, RA and TPA cell states. Plot line colors: O (undifferentiated), black; RA treated, red; TPA treated, blue.

undifferentiated cells, for the speciﬁc PML-associated
genes are frequently not the same for RA and TPA
treated cells, implying that the PML bodies likely have
different compositions in the 3 cell states. Figure 7B
and C present nucleosome occupancy and transcript
level changes for 2 important proteins of PML bodies
(PML and SP100), also implying differential gene regulation between the 3 cell states. Because PML bodies
appear to have multiple connections to stress
responses40 the compositional heterogeneity of PML
bodies suggests functional heterogeneity in the different cell states.

Discussion
The present study used antibodies against histone H3
and several histone modiﬁcations in a ChIP-seq study
of various nuclear elements (promoters, enhancers,
TF binding sites and epichromatin) on undifferentiated (0) and differentiated (RA and TPA treated)

forms of the myeloid leukemic cell line HL-60/S4.
This yielded information about the relation of nucleosome loss to gene expression changes, the effects on
nucleosome repeat length (NRL), nucleosome positions and nucleosome occupancy in and around
CTCF and PU.1 binding sites and within common epichromatin regions. We have found changes in nucleosome occupancy surrounding various histone
modiﬁcation domains and revealed the distribution of
histone modiﬁcations within and surrounding common epichromatin regions.
Our previous work on HL-60/S4 cells since 199817
was facilitated by their robust growth ability in the
undifferentiated state and their rapid and reproducible
cell differentiation in response to RA or TPA treatment. Furthermore, we recently obtained the transcriptomes of these 3 cell states (0, RA and TPA), and
demonstrated that these cells have a very stable
(abnormal) karyotype.27 Transcription factor binding
measurements in HL-60/S4 are still missing, but we
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can extrapolate, to some extent, from the ENCODE
ChIP-seq data for a related HL-60 cell line.34 All these
data complemented the experimental data obtained in
the current work, allowing us to perform the computational analyses.
Some of the most interesting conclusions from this
study are the following: 1) During RA and TPA
induced differentiation, regions that lost (but not
regions that gained) nucleosomes are enriched at
functional genomic elements such as promoters and
enhancers (Fig. 1A and B). The number of genes upregulated upon nucleosome loss at the corresponding
promoters was signiﬁcantly elevated in comparison
with genes that gained nucleosomes or in comparison
with all genes (Fig. 1C and D). Documenting this
observation, we presented a set of speciﬁc genes that
show increased transcript levels and decreased promoter nucleosome occupancy in the differentiated
state (Fig. 2). This observation has an intriguing parallel in the aforementioned transcriptome study,27
which demonstrated that following differentiation,
more genes contributed more mRNA transcripts than
genes that contributed decreased transcripts. 2) The
global nucleosome repeat length (NRL) of HL-60/S4
cells appears essentially unchanged during cell differentiation, in contrast to other cell differentiation systems,3 such as stem cells differentiation into neuronal
precursor cells and embryonic ﬁbroblasts. 3) The
NRLs around CTCF and PU.1 binding sites in undifferentiated and differentiated HL-60/S4 cells are about
10 bp shorter than the global NRL, arguing that transcription factor binding can lead to local changes of
NRL. 4) Nucleosome occupancies can also change
during HL-60/S4 differentiation in regions of speciﬁc
histone modiﬁcations; this is, for example, well
revealed around H3K4me3 domains. In the latter case,
we observed a signiﬁcant loss of nucleosomes following RA or TPA treatment (consistent with conclusion
#1 above). 5) Epichromatin regions in undifferentiated
and differentiated HL-60/S4 cells maintain their
unusual characteristics, consistent with earlier observations.23 Alu and nucleosomes exhibit their peak
densities at the “center” of the common epichromatin
regions, which also shows a “spike” in G/C richness,
compared with the surrounding regions. Common epichromatin regions also reveal a depletion of histone
post-translational modiﬁcations considered indicative
of either active or repressed transcription. In general,
epichromatin is not within the gene body, but rather,

is away from genes. If we assume that gene regulatory
regions can extend up to 1000 kb from the promoter
(unless it intersects another gene; the default parameter in the software GREAT41 used in this analysis),
then it appears that the regulatory regions responsible
for PML-associated genes (Supplementary Table 1)
are enriched in epichromatin. At least 2 of these
“close” promoters (i.e., for SP100 and DAXX) regulate
transcription for proteins that are key components of
ALT-associated PML bodies, believed to play a role in
telomere elongation independent of telomerase.42 The
large number of common chromosomal locations of
epichromatin, comparing the 3 cell states, suggests stability of nuclear architecture during the lineage differentiation of HL-60/S4 cells. It is important to
emphasize that epichromatin is identiﬁed by a conserved epitope (involving histones H2A, H2B and
DNA) that remains to be deﬁned, but likely represents
a highly conserved structural feature of nucleosomes.36,37 A recent study43 presents evidence that
etoposide-induced DNA damage of an embryonic
teratocarcinoma cell line results in a disappearance of
the peripheral epichromatin epitope in damaged
nuclei, but not in undamaged nuclei. The epitope disappearance may represent histone-DNA loss, histone
modiﬁcation or masking by other proteins, an intriguing probe for changes at the nuclear periphery.
Finally, the present manuscript argues that in HL60/S4 cells, there is a statistically signiﬁcant association between the loss of nucleosomes within gene promoters (in differentiated cells) and increased levels of
gene transcripts. Nucleosome depletion at promoters
in many systems is quantitatively linked to the level of
gene expression.3,28,44,45 However, it is also clear that
there are promoters that require the presence of nucleosomes to initiate the binding of transcription factors,
leading to subsequent transcription.46,47 Our observation that, during HL-60/S4 differentiation, nucleosome loss and nucleosome gain affect gene expression
asymmetrically (i.e., a clear association with nucleosome loss and a more complicated response to nucleosome gain) agrees with the concept that there are
several different mechanisms by which nucleosome
positioning can affect gene expression. Interestingly,
these changes in nucleosome occupancy involve
extended regions of one to several kb, which is different from previously considered single-nucleosome
repositioning scenarios and parallels a similar effect
recently found at the V(D)J recombination domains48
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The molecular mechanisms of the change of chromatin density in extended regions that we report here
may be linked to chromatin compartmentalization in
domains such as TADs (topologically associated
domains),49,50 which have been recently shown to be
correlated with regions of differential chromatin
accessibility.51 An exploration of this idea may provide
a direction for new studies.

Materials and methods
Cell culture and cell preparation

HL-60/S4 cells were maintained in RPMI 1640
medium, plus 10% fetal calf serum and 1% Pen/Strep/
Glutamine. This cell line is available from ATCC
(www.atcc.org, #CRL-3306). For the current experiments, cells were maintained in duplicate T-75 ﬂasks,
each ﬂask containing 30 ml. Undifferentiated HL-60/
S4 cells were seeded at a concentration of 0.83£105.
RA treated cells were seeded at a concentration of
1.67£105, with RA (Sigma-Aldrich R2625) added to
1 mM. TPA treated cells were seeded at a concentration of 4 £ 105, with TPA (Sigma-Aldrich P1585)
added to 16 nM. After 4 d, approximately 107 were
removed from each ﬂask.
Harvested cells were centrifuged at 300xg for 5 min,
resuspended in PBS and centrifuged again. The cell
pellets were suspended in 20 ml PBS, made 1%
HCHO (fresh ampule of 16% HCHO, methanol-free)
and incubated 10 min at RT on a rotator. Fixation was
stopped by addition of 2.5 M glycine to a ﬁnal concentration of 125 mM and incubated 5 min at RT on a
rotator. Fixed cells were centrifuged at 1000xg for
5 min and washed twice in PBS plus 50mM PMSF.
Cell pellets were suspended in 10 ml of ice-cold “swelling buffer” (10 mM KCl, 1 mM MgCl2, 0.1% NP-40,
1 mM DTT, 25 mM Hepes pH 7.8, made 0.5 mM
PMSF and containing Roche COMPLETE), incubated
10 min on ice, then centrifuged at 1000xg followed by
plunging the cell pellets in liquid N2.
ChIP-seq protocol

The frozen cell pellets were resuspended in MNase
(Micrococcal Nuclease) buffer (25 mM KCl, 4 mM
MgCl2, 1 mM CaCl2, 50 mM Tris/HCl pH 7.4) and
10 U MNase per 1£106 cells were added. After 15 min,
incubation at 37 C MNase was stopped by adding 10x
Covaris buffer (100 mM Tris pH 8.0, 2 M NaCl,
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10 mM EDTA, 5% N-lauroylsarcosine, 1% Na-deoxycholate, supplemented with protease inhibitors). The
samples were sonicated for 15 min with the following
parameters with a Covaris S2 system: burst 200, cycle
20%, and intensity 8. Following centrifugation the
supernatant was collected and directly used for IP.
After IgG preclearance the sheared chromatin was
incubated overnight with protein G magnetic beads
(Cell signaling, 9006) and 4 mg of anti-pan H3
(Abcam, ab1791), H3K4me1 (Abcam, ab8895),
H3K4me3 (Abcam, ab8580), H3K9ac (Active Motif,
39917), H3K9me3 (Abcam, ab8898), H3K27ac
(Abcam, ab4729) or H3K27me3 (Abcam, ab6002),
H3K36me3 (Abcam, ab9050). After washes with 1x
Covaris buffer (10 mM Tris–HCl, pH 8.0, 200 mM
NaCl, 1 mM EDTA, 0.5% N-lauroylsarcosine, 0.1%
Na–deoxycholate), high-salt-buffer (50 mM HEPES
pH 7.9, 500 mM NaCl, 1mM EDTA, 1% Triton X100, 0.1% Na–deoxycholate, 0.1% SDS), lithium buffer
(20 mM Tris–HCl pH 8.0, 1 mM EDTA, 250 mM
LiCl, 0.5% NP-40, 0.5% Na–deoxycholate) and
10 mM Tris–HCl, chromatin was eluted from the
magnetic beads (elution buffer: 50 mM Tris pH 8.0,
1 mM EDTA, 1% SDS, 50 mM NaHCO3) and the
crosslink was reversed overnight. After RNase A and
proteinase K digestion, DNA was puriﬁed and cloned
in a barcoded sequencing library for the Illumina
sequencing platform. In brief, after DNA repair and
A-addition NEBNext adapters (NEB, E7335) were
ligated and digested with the USER enzyme. Barcodes
(NEB, E7335) were introduced via PCR with a maximum of 14 cycles by the NEBNext polymerase (NEB,
M0541). Size selection for mononucleosomal insert
fragments was done with Ampure XP beads (Agencourt, A63880). Each ChIP-seq library was sequenced
on the Illumina HiSeq 2000 with 50bp single-end in 2
replicates, whereas the H3-chip samples were
sequenced with 50 bp paired-ends in 2 replicates.
Analysis of H3 ChIP-seq

H3 ChIP-seq reads were mapped using Bowtie52
allowing up to 1 mismatch and counting only
unique hits, obtaining the following number of
mapped 100-bp paired-end reads: 248 million for
undifferentiated HL-60/S4 cells, 319 million for RAtreated HL-60/S4, and 338 million reads for TPAtreated HL-60/S4. The average DNA fragments
lengths were correspondingly 160 bp, 159 bp and
159 bp, reﬂecting a moderate chromatin digestion
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(in a strongly digested chromatin DNA fragments
are closer to the 147bp nucleosome DNA length).
Mapped reads were processed using NucTools31 to
generate genome-wide nucleosome occupancy landscapes, extract individual genomic regions and calculate NRL, as described previously.3,33,53 Aggregate
nucleosome occupancy proﬁles around genomic features were calculated using HOMER54 and visualized using OriginPro 2016 (OriginLab Corporation).
For the analysis performed in this manuscripts, we
used the corresponding RefSeq deﬁnitions of promoters55 (extended C/¡1,000 from TSS), FANTOM
deﬁnitions of enhancers56 and Dfam deﬁnitions of
ALU repeats.57 The coordinates of transcription factor binding sites and DNaseI-sensitive regions in
HL-60 cells determined by the ENCODE consortium were obtained from the following GEO entries:
GSM749688 (CTCF), GSM1010843 (PU.1) and
GSM736626 (DNaseI hypersensitivity).

Analysis of RNA-seq data

Analysis of ChIP-seq of histone modiﬁcations

Epichromatin coordinates

The basic data processing was performed similarly to
H3 ChIp-seq, with a difference that these were singleend reads, and the sequencing was to a smaller depth
(30–40 million reads for each of 6 histone modiﬁcation for each of the 3 cell conditions). Peak calling was
performed using HOMER and repeated with MACS58
and SICER59 to conﬁrm that the number of peaks did
not differ signiﬁcantly for different peak calling procedures. In the case of H3K4me3, the data from the
ENCODE consortium obtained for HL-60 cells
(GSM945222) had higher genomic coverage than our
H3K4me3 ChIP-seq in HL-60/S4, but the aggregate
proﬁles around genomic features were qualitatively
similar.

Coordinates of epichromatin domains in undifferentiated HL-60/S4 and RA-differentiated cells were determined in our previous publications using modiﬁed
immunoprecipitation method (“xxChIP-seq”) with
PL2–6 and 1H6 antibodies.23 Here we have deﬁned a
subset of these regions that was reproduced in all replicate experiments with both antibodies, both in undifferentiated HL-60/S4 and RA-differentiated cells.
Deﬁned in this way, replicate PL2–6 immunoprecipitates of undifferentiated HL-60/S4 cells exhibited
40,288 epichromatin regions; replicate RA-treated
cells, 77,897 regions. Deﬁning only common regions
based on all replicates, both antibodies (PL2–6 and
1H6) and both cell states (undifferentiated and RAtreated) resulted in 6,541 epichromatin regions.

We used RNA-seq data for undifferentiated HL-60/
S4 and RA- and TPA-differentiated counterparts (4
replicates for each state) reported in the accompanying paper (Mark Welch et al, Nucleus, in press;
deposited at the Short Read Archive (SRA), bioproject PRJNA303179). Because different methods can
produce inconsistent results60-62 we measured genelevel differential expression using DESeq2,63
EBSeq,64 EdgeR,65 and limma-voom.66 For our
data, EBSeq proved the most conservative, with the
fewest genes called as signiﬁcantly differentially
expressed and the fewest genes called, that were
not called by other methods (Supplemental Table 2).
Therefore, only genes that EBSeq determined to
have posterior probability of differential expression
(PPDE) >0.95 were considered in the analysis
(Supplemental Table 3).

Finding genomic regions which lost/gained
nucleosomes

Enrichment analysis

1000-bp regions which lost or gained nucleosome
were determined genome-wide using NucTools31 with
the following criteria applied to the pairs of cell states
(e.g. RA vs 0): If the average nucleosome occupancy in
RA-treated cells (PRA) in a given genomic window
was higher than that in the control state (P0), i.e., if 2x
(PRA – P0)/(PRA C P0) > 0.99 this was assigned as a nucleosome gain region. If 2x (PRA – P0)/(PRA C P0) < ¡0.99
the corresponding region was considered to have a
nucleosome loss.

Enrichment of genomic regions which lost or gained
nucleosomes at functional genomic elements (promoters, enhancers, Alu repeats) was calculated as a
ratio of several regions falling to a given class of functional elements vs. the number of random regions
(generated for a data set of the same and with the
same region length distribution) falling to a given class
of functional elements. Random regions were generated using BedTools.67 Gene Ontology enrichment at
promoters with differential nucleosome occupancy
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was calculated using DAVID68 (2016 update) with
default parameters. The enrichment of epichromatin
regions in functional regulatory elements was calculated using GREAT41 with the following parameters:
Each gene was assigned a basal regulatory domain of
5kb upstream and 1kb downstream of the TSS
(regardless of other nearby genes). The gene regulatory domain is extended in both directions to the
nearest gene’s basal domain but no more than 1000kb
in one direction.
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